Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC414

Melfalan flúfenamíð hýdróklóríð

  • Status:
    Veitt
  • Application date:
    14.12.2022
  • Application published:
    15.1.2023
  • Grant published:
    15.10.2025
  • Max expiry date:
    24.4.2037
  • Medicine name:
    Pepaxti
  • Medicine for children:
    No

Timeline

Today
14.12.2022Application
15.1.2023Publication
15.10.2025Registration
24.4.2037Expires

Marketing license

  • IS authorization number:
    EU/1/22/1669
  • Date:
    23.8.2022
  • Foreign authorization number:
    EU/1/22/1669
  • Date:
    17.8.2022

Owner

  • Name:
    Oncopeptides Innovation AB
  • Address:
    Luntmakargatan 46, 111 37 Stockholm SE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Formgallafrestur, fyrsti

Deadline until: 20.03.2023

Upload documents